Carrageenan: the ingredient with the longest-running argument

Few additives generate as much heat as carrageenan. It has been petitioned against, removed from products, reinstated, and reviewed repeatedly by regulators who keep arriving at cautious approval.

The argument is more tractable than it looks once you separate two things that get conflated.

Two substances, one word

Carrageenan is extracted from red seaweed and used to thicken and stabilise. Food-grade carrageenan is a large molecule — too large to be absorbed intact.

Degraded carrageenan, sometimes called poligeenan, is a much smaller molecule produced by treating carrageenan with acid and heat under conditions far harsher than food processing. It is not a food additive. It is a laboratory reagent, used specifically because it reliably produces intestinal inflammation in animal models.

A large share of the alarming literature uses the degraded form. Reading those results as though they apply to the food ingredient is the central error in most of the coverage.

The part that is genuinely unresolved

The steel-man of the concern is not the poligeenan studies. It is the question of whether food-grade carrageenan contains some fraction of lower-molecular-weight material, and whether normal digestion generates any.

Regulators have looked at this directly. The reviews have generally concluded that the evidence does not support a hazard at the levels used, while noting that data on the low-molecular-weight fraction is thinner than anyone would like and asking for more of it. That is a real caveat, not a clean bill of health.

Why it stays in products

Carrageenan does something the obvious substitutes do not do as well. It suspends particles in liquid without adding perceptible texture, which is why it appears in dairy alternatives and drinks. Reformulating around it usually means guar gum, xanthan gum, or gellan, each with their own trade-offs in mouthfeel and their own tolerance profiles.

Several manufacturers removed it anyway, largely in response to consumer pressure rather than a regulatory change.

A reasonable position

If you have inflammatory bowel disease, the caution is more defensible — that is the population where the theoretical mechanism would matter most, and it is also where the data is thinnest. For most people, the evidence does not support avoidance, and the gums that replace it are not obviously better.

The carrageenan report carries the regulatory positions, what each review concluded, and the alternatives, so you can see exactly where the uncertainty sits rather than picking a side from headlines.